What is the best salvage therapy for treatment of isolated CNS relapse in elderly patients with imatinib-responsive Ph+ ALL?

Leukemia Research

Volumn 31, Issue 10, 2007, Pages 1445-1447

  Mele, Giuseppe ^a   Pinna, Salvatore ^a   Melpignano, Angela ^a   Romano, Antonio ^a   Brocca, Maurizio Claudio ^a   Coppi, Maria Rosaria ^a   Quarta, Giovanni ^a  

^a PERRINO HOSPITAL   (Italy)

Author keywords

Elderly patients; Imatinib; Meningeal leukaemia; Ph+ ALL

Indexed keywords

ALLOPURINOL; CIPROFLOXACIN; CYTARABINE; FLUCONAZOLE; HYDROCORTISONE; IMATINIB; METHOTREXATE; PREDNISONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BACTERIAL INFECTION; BONE MARROW; BRAIN RADIATION; CANCER RADIOTHERAPY; CANCER RELAPSE; CASE REPORT; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG TREATMENT FAILURE; HUMAN; LEUKEMIC MENINGITIS; LIVER TOXICITY; MALE; MYCOSIS; PHILADELPHIA CHROMOSOME POSITIVE CELL; PRIORITY JOURNAL; SALVAGE THERAPY;

ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; CYTARABINE; HUMANS; HYDROCORTISONE; INJECTIONS, SPINAL; MALE; MENINGEAL NEOPLASMS; METHOTREXATE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PIPERAZINES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PYRIMIDINES; RADIOTHERAPY; SALVAGE THERAPY;

EID: 34547686249     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.03.018     Document Type: Article

References (10)

1. Hoelzer D., and Gökbuget N. Recent approaches in acute lymphoblastic leukaemia in adults. Crit Rev Oncol Hematol 36 (2000) 49-58
2. Vignetti M., Fazi P., Meloni G., et al. Dramatic improvement in CR rate and CR duration with imatinib in adult and elderly Ph+ ALL patients: results of the GIMEMA prospective study LAL0201. Blood 104 (2004) [Abstract 2739]
3. Ottmann O.G., Wassmann B., Gökbuget N., et al. A randomized phase II study comparing imatinib with chemotherapy as induction therapy in elderly patients with newly diagnosed Philadelphia-positive acute lymphoid leukemias. Hematol J 5 (2004) S112
4. Takayama N., Sato N., O'Brien S., et al. Imatinib mesylate has limited activity against the central nervous system involvement of Philadelphia chromosome-positive acute lymphoblastic leukaemia due to poor penetration into cerebrospinal fluid. Br J Haematol 119 (2002) 106-109
5. Petzer A.L., Gunsilius E., Hayes M., et al. Low concentrations of STI571 in the cerebrospinal fluid: a case report. Br J Haematol 117 (2002) 623-625
6. Pfeifer H., Wassmann B., Hofmann W.K., et al. Risk and prognosis of central nervous system leukemia in patients with philadelphia chromosome-positive acute leukemias treated with imatinib mesylate. Clin Cancer Res 9 (2003) 4647-4681
7. Dai H., Marbach P., Lemaire M., et al. Distribution of STI571 to the brain is limited by p-glycoprotein-mediated efflux. J Pharmacol Exp Ther 304 (2003) 1085-1092
8. Brooks J., Bani J.C., Fletcher C.D.M., et al. Case 4 response of metastatic gastrointestinal stromal tumor including CNS involvement to imatinib mesylate (STI-571). J Clin Oncol 20 (2002) 870-872
9. Glantz M.J., LaFollette S., Jaeckle K.A., et al. Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol 17 (1999) 3110-3116
10. Gökbuget N., and Hoelzer D. Meningeosis leukaemia in adult acute lymphoblastic leukaemia. J Neuro-oncol 38 (1998) 167-180